AirXpanders and Radformation announce co-marketing agreement

SAN JOSE, California, April 7, 2019 / PRNewswire / – AirXpanders, Inc. (ASX: AXP), a medical device company specializing in the design, manufacture, sale and distribution of the AeroForm® tissue expansion system, and Radformation, Inc., A software company co-founded by medical physicists dedicated to the integration of intelligent automation software in cancer treatment, including the planning of radiation therapy treatments for bad and bad reconstruction, has today announced the signing of a co-marketing agreement to introduce EZFluence Radformation software into radiation oncology services. who treat AeroForm patients in the United States.

The co-marketing agreement allows AirXpanders sales staff to introduce EZFluence software to radiation oncology departments that are treating an increasing number of patients with the AeroForm Tissue Expander system. This collaboration is expected to improve the acceptance of the AeroForm Expander by dramatically improving the workflow required to develop radiation therapy plans. By collaborating on the introduction of the EZFluence software, both organizations expect radiation oncology departments to benefit from the intelligent automation of radiotherapy treatment planning for bad reconstruction patients.

"We were very impressed with the EZfluence software," he said. Mark Payne, Vice President, Research and Development, AirXpanders. "The intelligent automation provided by this software for opposing tangent fields, utilizing both field-field and E-Comp field techniques, is impressive in its thoroughness and ability to efficiently develop a plan Radiotherapy treatment in minutes from a patient's scanner.The homogeneity of this software is significantly improved over conventionally defined iterative plans.We expect the radiation-oncology departments to appreciate significantly reducing the time it takes to develop a treatment plan for patients with AeroForm and increasing overall productivity for all patients, we're excited to be training our team and presenting our customers with this progress. of automation of radiotherapy treatment planning. "

"Radformation is excited about working with a company that empowers patients and values ​​their interests," he said. Elisabeth van Wie, Medical Physicist and Director of Radformation Affairs.

"The goal of AirXpanders is to make the patient more comfortable during a difficult period of his life while maintaining quality treatment.We support this goal and look forward to working with clinics to generate plans for optimal radiotherapy for patients. "

EZFluence Radformation is FDA-approved and has been available in the US since 2017. With a rapidly growing installed base, a growing number of radiation oncologists and medical physicists are using the system and seeing the productivity improvements that it has. offer. As a plug-in script for Varian's Eclipse system, EZFluence is simple to use and easy to adopt.

"EZFluence is the best friend of a treatment planner for all shots using opposing beams." The AeroForm tissue expander poses unique challenges, but with EZFluence, we were able to get an optimal shot in record time ", said Scott Dube, Medical Physicist at Morton Plant Hospital, Clearwater, FL.

As part of this agreement, the companies are developing collaboration and education plans at key meetings of the Radiation Oncology and Medical Physics Society in 2019.

About AirXpanders

Founded in 2005, AirXpanders, Inc. (www.airxpanders.com) designs, manufactures and markets innovative medical devices to improve bad reconstruction. The Company's AeroForm Tissue Expansion System is used in patients undergoing two-stage bad reconstruction after mastectomy. Headquarters at San Jose, CaliforniaAirXpanders' vision is to be the world leader in reconstructive surgery products and to become the standard of two-step bad reconstruction care. AirXpanders is a company listed on the Australian Securities Exchange under the symbol "AXP". In 2016, AeroForm obtained the US FDA marketing authorization. After authorization from the US market in 2017, the first CE marking of Europe  in 2012, and is currently licensed for sale in Australia.

About the training

Radformation is a team of medical physicists and medical device experts who designs software to automate the workflow in the treatment of cancer. Radformation currently markets two FDA-approved products, including the ClearCheck One-Click plan evaluation software for radiotherapy plans and the EZFluence One-Click 3D planning software for intelligent 3D bad radiotherapy plan automation, brain, lungs and others. Radformation is a private company.

Forward-Looking Statements Regarding AirXpanders

This announcement contains or may contain forward-looking statements that are based on the beliefs, badumptions and expectations of management and the information currently available to management.

All statements that address operational performance, events or developments that we anticipate or expect to occur in the future are forward-looking statements. These include, but are not limited to, the ability of EZFluence to improve the acceptance of AeroForm, the expected benefits of radiation oncology services, the effectiveness of plans. treatment developed with the help of the software, as well as the ease of use and adoption of EZFluence.

Management believes that these forward-looking statements are reasonable when made. You should not place undue reliance on forward-looking statements as they are valid only as of the date they are made. AirXpanders may not meet the objectives, forecasts or forecasts in forward-looking statements. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements. For more information and considerations about the risks incurred by AirXpanders that could cause a material difference in actual results, see its latest annual report on Form 10-K, filed with the Securities and Exchange Commission on February 28, 2019, including under "Risk Factors", as well as other periodic reports filed with the SEC from time to time. AirXpanders disclaims any obligation to update the information contained in any forward-looking statement, except as required by law.

For more information about AeroForm or AirXpanders, Inc., please visit the company's website at www.airxpanders.com.

For more information on EZFluence or Radformation, Inc., please visit the company's website at http://www.EZFluence.com. www.radformation.com

SOURCE AirXpanders, Inc.

Related Links

http://www.airxpanders.com